<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Addict Behav</journal-id><journal-id journal-id-type="iso-abbrev">Addict Behav</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Addictive behaviors</journal-title></journal-title-group><issn pub-type="ppub">0306-4603</issn><issn pub-type="epub">1873-6327</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6078786</article-id><article-id pub-id-type="pmcid-ver">PMC6078786.1</article-id><article-id pub-id-type="pmcaid">6078786</article-id><article-id pub-id-type="pmcaiid">6078786</article-id><article-id pub-id-type="manuscript-id">NIHMS971327</article-id><article-id pub-id-type="pmid">29754987</article-id><article-id pub-id-type="doi">10.1016/j.addbeh.2018.04.020</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS971327</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA971327</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Statewide Effort to Reduce High-Dose Opioid Prescribing Through Coordinated Care Organizations</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Hartung</surname><given-names initials="DM">Daniel M.</given-names></name><degrees>PharmD, MPH</degrees><xref ref-type="aff" rid="A1">a</xref><xref ref-type="aff" rid="A2">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Alley</surname><given-names initials="L">Lindsey</given-names></name><degrees>MS</degrees><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Leichtling</surname><given-names initials="G">Gillian</given-names></name><xref ref-type="aff" rid="A3">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Korthuis</surname><given-names initials="PT">P. Todd</given-names></name><degrees>MD, MPH</degrees><xref ref-type="aff" rid="A1">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hildebran</surname><given-names initials="C">Christi</given-names></name><degrees>LMSW</degrees><xref ref-type="aff" rid="A3">c</xref></contrib></contrib-group><aff id="A1">
<label>a</label>Oregon Health &amp; Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239</aff><aff id="A2">
<label>b</label>Oregon State University College of Pharmacy, 2730 SW Moody Ave., CL5CP, Portland, OR 97201</aff><aff id="A3">
<label>c</label>HealthInsight Oregon, 2020 SW 4th Avenue, Suite 520 Portland, OR 97201</aff><author-notes><corresp id="FN1">Corresponding Author: Inquiries regarding this manuscript should be directed to Daniel Hartung, MPH, PharmD, at the Oregon State University College of Pharmacy, 2730 SW Moody Ave., CL5CP, Portland, Oregon 97201-5042; (503) 494-4720; <email>hartungd@ohsu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>01</day><month>5</month><year>2018</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2018</year></pub-date><volume>86</volume><issue-id pub-id-type="pmc-issue-id">318263</issue-id><fpage>32</fpage><lpage>39</lpage><pub-history><event event-type="nihms-submitted"><date><day>02</day><month>06</month><year>2018</year></date></event><event event-type="pmc-release"><date><day>01</day><month>11</month><year>2019</year></date></event><event event-type="pmc-live"><date><day>01</day><month>11</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-18 05:25:29.310"><day>18</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms971327.pdf"/><abstract><sec id="S1"><title>Background</title><p id="P1">Oregon&#8217;s Medicaid program is delivered through 16 Coordinated Care Organizations (CCOs) participating in a statewide performance improvement program to reduce high-dose opioid prescribing. CCOs were allowed flexibility to develop their own dose targets and any policies, trainings, guidelines, and/or materials to meet these targets. In this study, we characterize CCO strategies to reduce high-dose opioid prescribing across the 16 CCOs.</p></sec><sec id="S2"><title>Methods</title><p id="P2">We reviewed relevant CCO documents and conducted semi-structured interviews with CCO administrators to acquire opioid-related policies, practices, timelines and contextual factors. We applied a systematic coding procedure to develop a comprehensive description of each CCO&#8217;s strategy. We used administrative data from the state to summarize contextual utilization data for each CCO.</p></sec><sec id="S3"><title>Results</title><p id="P3">Most CCOs selected a target daily morphine milligram equivalent (MME) dose of 90 mg. Sixteen issued quantity limits related to dose, eight restricted specific drug formulations (short-acting or long-acting), and 11 allowed for time-limited taper plan periods for patients over threshold. Many CCOs also employed provider trainings, feedback reports, and/or onsite technical assistance. Other innovations included incentive measures, electronic health record alerts, and toolkits with materials on local alternative therapy resources and strategies for patient communication. CCOs leveraging collaborations with regional partners appeared to mount a greater intensity of interventions than independently operating CCOs.</p></sec><sec id="S4"><title>Conclusions</title><p id="P4">CCOs developed a diversity of interventions to confront high-risk opioid prescribing within their organization. As healthcare systems mount interventions to reduce risky opioid prescribing, it is critical to carefully describe these activities and examine their impact on process and health outcomes.</p></sec></abstract><kwd-group><kwd>Opioid</kwd><kwd>coordinated care</kwd><kwd>opioid safety interventions</kwd><kwd>opioid policy</kwd><kwd>tapering</kwd><kwd>prescribing limits</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>